JIR
RMD icon

James Investment Research’s ResMed RMD Stock Holding History

James Investment Research’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-125
Closed -$27K – 479
2023
Q1 		$27K Hold
125
– – ﹤0.01% 419
2022
Q4 		$26K Sell
125
-901
-88% -$198K ﹤0.01% 426
2022
Q3 		$224K Sell
1,026
-45
-4% -$10.2K 0.03% 246
2022
Q2 		$225K Sell
1,071
-10,269
-91% -$2.19M 0.03% 247
2022
Q1 		$2.75M Sell
11,340
-5,916
-34% -$1.43M 0.29% 90
2021
Q4 		$4.5M Sell
17,256
-266
-2% -$69K 0.41% 72
2021
Q3 		$4.62M Buy
17,522
+64
+0.4% +$17.5K 0.43% 71
2021
Q2 		$4.3M Buy
17,458
+561
+3% +$118K 0.37% 82
2021
Q1 		$3.28M Buy
16,897
+16,611
+5,808% +$3.33M 0.3% 98
2020
Q4 		$61K Buy
286
+69
+32% +$13.8K 0.01% 366
2020
Q3 		$37K Buy
+217
New +$40.1K ﹤0.01% 366

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

James Investment Research's RMD Position: Q2 2023 in Review

James Investment Research sold out of ResMed (RMD) in Q2 2023, closing a stake of 125 shares — an estimated $27K sold.

James Investment Research first reported a position in RMD in Q3 2020 and held it in 11 quarters. The position peaked at $4.62M in Q3 2021. 731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

  • James Investment Research reported no remaining ResMed position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 125 ResMed shares in Q2 2023, an estimated $27K.
  • James Investment Research first reported a position in ResMed in Q3 2020 and held it in 11 quarters.
  • James Investment Research's ResMed position peaked at $4.62M in Q3 2021.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.